University of Notre Dame du Lac’s Vanda Pharmaceuticals VNDA Stock Holding History

University of Notre Dame du Lac’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-128,346	Closed	-$2.36M	–	72
2019 Q1	$2.36M	Buy	128,346 +30,825	+32%	+$702K	0.53%	58
2018 Q4	$2.55M	Buy	+97,521	New	+$2.29M	0.62%	45
2018 Q3	–	Sell	-163,626	Closed	-$3.12M	–	80
2018 Q2	$3.12M	Sell	163,626 -7,208	-4%	-$121K	0.6%	50
2018 Q1	$2.88M	Sell	170,834 -31,396	-16%	-$526K	0.54%	59
2017 Q4	$3.07M	Buy	202,230 +44,449	+28%	+$660K	0.64%	53
2017 Q3	$2.82M	Buy	+157,781	New	+$2.64M	0.79%	56
2017 Q2	–	Sell	-176,056	Closed	-$2.46M	–	89
2017 Q1	$2.46M	Buy	+176,056	New	+$2.51M	0.62%	58

Other funds holding VNDA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

University of Notre Dame du Lac's VNDA Position: Q2 2019 in Review

University of Notre Dame du Lac sold out of Vanda Pharmaceuticals (VNDA) in Q2 2019, closing a stake of 128,346 shares — an estimated $2.36M sold.

University of Notre Dame du Lac first reported a position in VNDA in Q1 2017 and held it in 7 quarters. The position peaked at $3.12M in Q2 2018. 164 funds tracked by Wall St. Rank hold VNDA as of Q2 2019.

University of Notre Dame du Lac reported no remaining Vanda Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
University of Notre Dame du Lac sold 128,346 Vanda Pharmaceuticals shares in Q2 2019, an estimated $2.36M.
University of Notre Dame du Lac first reported a position in Vanda Pharmaceuticals in Q1 2017 and held it in 7 quarters.
University of Notre Dame du Lac's Vanda Pharmaceuticals position peaked at $3.12M in Q2 2018.
164 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2019.

Based on University of Notre Dame du Lac's 13F filing for Q2 2019, filed 14 Aug 2019.